From Canadian Money Magazine -- CELZ mention as breakout

From Canadian Money Magazine -- CELZ mention as breakout microcap

MutualFund.ca
Mutual Funds Canada
The American Dollar
The MONEY® Channel
The Montreal Star
Questions - Answers
YOU and YOUR MONEY®
Search Blog

Categories
24/7 PRESS RELEASE
ACCESSWIRE
FSCWIRE
NEWSFILECORP
July 2018
M T W T F S S
« Jun
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31
Tags
Micro Cap Companies that Have Explosive Features
ACCESSWIRE

By ACR Communication, LLC

LAS VEGAS, NV / ACCESSWIRE / July 9, 2018 / For the most part, micro cap stocks don’t get much attention from Wall Street analysts because they have little incentive to cover them. Analysts tend to cover stocks that their banks do business with or have the potential to in the near future.

It’s not uncommon for smaller stocks to have higher performances for your portfolio and there is enough reward to make it worthwhile. A large amount of micro cap’s are viewed as growth stocks. For this reason micro caps will experience greater volatility than large cap companies. Nonetheless, the huge potential of future growth drives investors into these micro cap companies despite experiencing large price swings.

When investing in micro cap companies an investor should pay attention to global trends. Determining what sectors of the economy should see growth in the future is important. Investors must perform due diligence before investing because some companies will attempt to ride the coattails of hot sectors. We’ve seen this recently in sectors like cannabis, blockchain, and artificial intelligence.

These micro cap companies have explosive features with big upside potential: APT Systems Inc (APTY), Drone USA, Inc. (DRUS), MariMed Inc. (OTCQB: MRMD), Vitality Biopharma, Inc. (VBIO), Creative Medical Technology Holdings, Inc. (CELZ)

APT Systems Inc. (APTY)

Market Cap: $1.74M, current share price: $.005

APT Systems Inc. is a company that specializes in the creation of innovative stock research tools, an equities trading platform called Intuitrader and delivering visualization solutions for the financial markets. We have dedicated charting indicators and apps under the brand KenCharts that we intend to expand into tracking cryptocurrencies. APT Systems recently launched its subsidiary SNAPT Games to further facilitate long term goals. We have acquired and are developing games for handheld devices with a view to using some of the gaming technology inside the trading platforms. We are also working with charities in order to support their good work through proceeds from the games. The Management of APT Systems, Inc. works to deliver stock trading tools while also strategically acquiring other compatible financial businesses which demonstrate strong growth potential. We are continuing our diligent search in order to buy software products that would enhance our operations. We are monitoring the dialogue on the proposed legislation for a Fintech National Banking Charter and how it can positively impact our operations.

Drone USA, Inc. (DRUS)

Market Cap: $1.26M, current share price: $.01

Drone USA, Inc., is a technology company, focusing on the research, design, development, testing, manufacture, distribution, export, and integration of advanced low altitude unmanned aerial vehicles systems, services, and products. It offers quadcopter and fixed-wing unmanned aerial vehicles to government and commercial markets. The company, through its subsidiary, HowCo Distributing Co., also provides product procurement, distribution, and logistics services to the United States Department of Defense and Defense Logistics Agency. In addition, it provides drone operator training services; and licensed piloted services, such as search and rescue, utility inspection, real estate marketing, construction, engineering, and agriculture. Further, the company offers spare and replacement parts to various federal government agencies, the U.S. military prime contractors, and commercial customers worldwide.

MariMed Inc. (OTCQB: MRMD)

Market Cap: $568.77M, current share price: $2.94

MariMed Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. MariMed’s team has developed state-of-the-art, regulatory-compliant legal cannabis facilities in multiple states. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed cannabis medicine for the treatment of specific medical conditions. MariMed branded products are being licensed and distributed in legal cannabis states across the country.

Vitality Biopharma, Inc. (VBIO)

Market Cap: $48.74M, current share price: $2.00

Vitality Biopharma is developing proprietary cannabinoid pharmaceuticals for treatment of serious neurological and inflammatory disorders. Vitality’s targeted prodrug technology enables delivery of cannabinoids to the site of disease while reducing or eliminating psychoactivity.

Creative Medical Technology Holdings, Inc. (CELZ)

Market Cap: $33.87M, current share price: $.05

Creative Medical is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility and related issues. It holds a patent for its erectile dysfunction (“ED”) treatment and was granted a license by Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, a non-profit biomedical research and education institute (“LABIOMED”), for the infertility treatment. It has also filed a patent application focused on physical manifestations of female sexual arousal disorder, as an extension of the work with stem cell therapies for ED. Following testing of its ED treatment, Creative Medical intends to market treatment kits to physicians for use with their patients suffering from ED. During first quarter 2016, it commenced a 15-month clinical trial study being conducted at UCLA by LABIOMED on the efficacy and safety of the ED treatment. The study involves testing on 40 subjects.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and one thousand dollars total by Regal Consulting, LLC, for APTY. APTY and Regal Consulting, LLC was given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which beliefs the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty-eight hours after this article’s distribution.

For Full Legal Disclaimer Click Here.